MIA Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-26185
Key Product Details
Species Reactivity
Human
Applications
Peptide ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Peptide with sequence PKLADRKLCADQE corresponding to internal region according to NP_006524.1.
Specificity
The immunizing peptide represents the N terminus of the mature protein. Reported variants represent identical protein: NP_006524.1, NP_001189482.1,
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for MIA Antibody
![Western Blot: MIA Antibody [NBP2-26185]](https://resources.bio-techne.com/images/products/MIA-Antibody-Western-Blot-NBP2-26185-img0001.jpg "Western Blot: MIA Antibody [NBP2-26185]")
Western Blot: MIA Antibody [NBP2-26185]
Western Blot: MIA Antibody [NBP2-26185] - Staining of Human Glioma lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.Applications for MIA Antibody
Application
Recommended Usage
Peptide ELISA
Detection limit 1:64000
Western Blot
1 - 3 ug/ml
Application Notes
WB: Approx. 14 kDa band observed in human Glioma lysates (calculated MW of 14.5 kDa band according to NP_006524.1).
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: MIA
Long Name
Melanoma Inhibitory Activity
Alternate Names
CD-RAP
Entrez Gene IDs
8190 (Human)
Gene Symbol
MIA
Additional MIA Products
Product Documents for MIA Antibody
Product Specific Notices for MIA Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...